Stock listing

TWSE:4737 Bionime Corporation (華廣) 股價

Follow Bionime Corporation into a list and get an email when it puts out news.

Share price · TWSE:4737

$58.00 TWD -1.40 (-2.4%)

Close on Nov 20, 2026

Past year -4.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$57.10 – $58.90 TWDNov 20, 2026
Volume
134,698 sharesNov 20, 2026
Market cap
$4.48B TWDAt the close on Nov 20, 2026 · price × 77.29M shares outstanding
52-week range
$49.75 – $72.90 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$4.90M TWDMedian day 54,564 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bionime Corporation logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:4737 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$58.00-1.40-2.4%$57.60$58.90$57.10134,698
$59.40-0.20-0.3%$59.60$62.00$59.20164,017
$59.60+2.90+5.1%$56.60$61.50$56.40336,512
$56.70+0.60+1.1%$55.50$56.90$55.2032,004
$56.10+0.80+1.4%$55.90$56.80$55.9025,010
$55.30-0.40-0.7%$57.10$57.70$55.3053,033
$55.70+0.20+0.4%$55.10$55.70$55.1011,037
$55.50-1.80-3.1%$55.50$56.70$55.4052,118
$57.30+1.50+2.7%$56.60$58.00$56.0062,641
$55.80-0.20-0.4%$50.60$55.80$50.6089,321
$56.00-0.90-1.6%$56.90$57.00$55.3045,331
$56.90-1.50-2.6%$57.70$57.70$55.0098,249
$58.40-0.70-1.2%$58.70$59.40$57.3093,288
$59.10-6.50-9.9%$64.80$64.80$59.10256,986
$65.60+5.30+8.8%$60.60$65.60$59.70453,668
$60.30+0.30+0.5%$60.00$60.50$59.2070,225
$60.00-0.50-0.8%$60.60$60.80$59.5083,517
$60.50+0.60+1.0%$58.10$60.50$57.80103,763
$59.900.000.0%$59.90$59.90$59.900
$59.90+2.90+5.1%$57.20$59.90$56.6064,203
$57.00+1.00+1.8%$56.10$57.00$56.0049,277
$56.00-0.50-0.9%$55.10$56.50$55.1051,004
$56.500.000.0%$57.00$57.00$55.9070,010
$56.50+1.10+2.0%$55.50$56.80$55.5084,107
$55.40+0.10+0.2%$55.30$55.60$54.4055,127
$55.30-0.70-1.3%$56.00$56.00$54.4044,050
$56.00-0.20-0.4%$56.20$56.20$54.9041,100
$56.20+1.20+2.2%$56.10$56.50$55.8013,000
$55.000.000.0%$55.50$55.60$54.8018,000
$55.00-0.30-0.5%$55.40$55.70$55.0045,000
$55.300.000.0%$56.70$56.70$55.2024,000
$55.30-1.00-1.8%$56.80$56.80$55.2044,000
$56.30+0.90+1.6%$56.30$56.30$55.0050,000
$55.400.000.0%$55.30$56.10$55.0038,000
$55.40-0.20-0.4%$56.40$56.70$55.4045,691
$55.60-0.70-1.2%$56.80$56.80$55.5021,000
$56.30-1.60-2.8%$57.10$57.10$55.8070,001
$57.90-1.70-2.9%$59.60$59.80$57.9043,000
$59.60-0.90-1.5%$60.40$60.40$59.6023,000
$60.50+0.20+0.3%$60.20$60.50$59.9051,815
$60.300.000.0%$60.70$60.80$59.3061,000
$60.30+0.60+1.0%$59.60$60.50$58.20154,000
$59.70+3.20+5.7%$56.40$59.80$55.80344,005
$56.50+2.50+4.6%$54.00$56.50$53.3061,687
$54.00-4.40-7.5%$57.50$58.40$53.20210,001
$58.40+0.10+0.2%$58.20$58.40$56.9078,000
$58.30+0.10+0.2%$58.20$58.40$57.6081,000
$58.20-0.60-1.0%$58.80$58.80$57.7098,270
$58.80-0.20-0.3%$58.70$58.80$57.2082,000
$59.00+0.40+0.7%$58.60$59.10$58.30157,001
$58.60+0.90+1.6%$57.80$58.80$57.30208,000
$57.70+0.30+0.5%$57.40$57.70$56.8062,001
$57.40-0.10-0.2%$57.00$57.80$56.5053,000
$57.50-0.10-0.2%$57.00$57.60$56.7067,000
$57.60-0.20-0.3%$57.80$58.40$56.8054,000
$57.80+0.20+0.3%$57.70$58.30$57.00120,000
$57.600.000.0%$57.80$57.90$57.0029,300
$57.60+0.70+1.2%$56.90$57.70$56.9043,000
$56.90+0.40+0.7%$56.90$56.90$56.5024,000
$56.50-0.50-0.9%$57.20$57.30$56.5020,000
$57.00-0.30-0.5%$57.50$57.60$56.1041,000
$57.30+0.30+0.5%$57.40$57.60$57.0024,000

Splits

1 split · TWSE:4737 · every price before a split is adjusted for it

DayRatioWhat
11-for-10Split
Ticker
TWSE:4737
Asset type
Stock
Exchange
TWSE
Currency
TWD

Latest news

All Bionime Corporation news

Bionime Corporation on 6ix

News releases
10 in all · newest Aug 4, 2022 · oldest 2022

Valuation

Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$6.69B TWD
P/E
Loss
EV/sales
3.9×
EV/EBITDA
Negative EBITDA
Price/book
2.1×
Gross margin
32.7%
Operating margin
−18.0%
Net margin
−16.6%
Debt to equity
1.3×
Beta
No index for this market yet

Events

QuarterResultsShare move
Q2 2024Aug 14, 2024 · Before open+1.4%
Q1 2024May 10, 2024 · Before open−1.1%
Q1 2023May 10, 2023 · Before open+0.5%
Q4 2022Mar 15, 2023 · Before open−0.1%
Q3 2022Nov 10, 2022 · Before open+0.9%
Q2 2022Aug 31, 2022−3.8%
Q1 2022Jun 1, 2022+2.3%
Q4 2021Mar 2, 2022−0.6%
Q3 2021Dec 1, 2021+1.0%
Quarter to Jun 30, 2021Aug 11, 2021 · After close+0.7%
All 12 quarters
QuarterResultsShare move
Quarter to Mar 31, 2021May 12, 2021 · Before open−6.9%
Quarter to Dec 31, 2020Mar 3, 2021+0.1%

Open Events

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.84B1.93B1.76B2.21B1.85B1.67B2.17B2.01B1.82B1.74B
Cost of revenue1.21B1.17B1.04B1.21B1.07B919.5M1.22B1.09B1.02B969.8M
Gross profit627.8M768.4M715.6M1.00B783.1M749.1M948.4M917.0M795.8M770.5M
Research and development354.8M322.3M242.3M202.0M187.9M247.9M255.1M201.2M160.0M140.4M
Selling, general and administrative476.3M247.5M243.8M241.6M237.8M221.0M250.3M227.1M215.3M221.9M
Operating income-197.4M-129.1M-13.3M146.7M73.1M75.9M176.5M239.3M248.4M258.4M
Depreciation and amortization182.3M182.8M163.4M153.2M154.7M163.5M164.5M151.3M145.8M158.0M
EBITDA-15.1M53.8M150.1M299.9M227.7M239.4M341.0M390.6M394.2M416.4M
Interest expense64.9M62.2M48.2M30.6M19.1M21.6M31.8M29.0M22.5M22.4M
Income before tax-249.4M-185.7M-31.9M86.5M74.6M31.1M134.6M162.0M188.8M213.9M
Income tax-70.1M-59.7M-38.4M-5.34M-14.7M-32.4M27.9M34.1M39.2M35.1M
Net income-180.3M-127.2M6.21M91.0M87.4M62.4M106.3M128.0M149.6M178.8M
Earnings per share, basic-2.65-1.900.091.351.310.941.642.002.272.55

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents423.1M321.2M391.8M214.5M253.1M343.2M359.6M433.6M174.3M588.9M
Short-term investments61.9M61.4M57.4M63.4M59.8M56.0M22.4M38.6M312.3M400.0M
Receivables540.5M722.8M520.4M707.2M387.1M477.7M752.1M838.6M625.8M419.3M
Inventory456.4M571.1M491.3M538.4M590.2M520.1M395.4M412.4M364.4M310.9M
Current assets1.56B1.77B1.62B1.64B1.39B1.46B1.60B1.77B1.49B1.75B
Property, plant and equipment2.48B2.54B2.63B2.68B2.69B2.71B2.73B
Goodwill493.0M327.7M191.4M35.2M
Total assets5.70B5.78B5.30B4.98B4.56B4.49B4.40B4.59B4.37B4.65B
Accounts payable141.6M191.4M147.7M179.2M151.1M146.3M149.0M162.8M144.8M188.7M
Current liabilities2.08B2.31B1.61B1.41B1.33B1.24B1.38B1.48B1.56B1.26B
Long-term debt1.86B1.58B1.69B1.48B1.16B1.17B972.1M1.11B737.6M794.7M
Total debt3.06B3.17B2.82B2.27B2.03B2.01B1.85B2.12B1.86B1.56B
Total liabilities3.95B3.89B3.31B2.90B2.49B2.41B2.36B2.60B2.30B2.06B
Shareholders' equity1.75B1.88B1.99B2.07B2.07B2.07B2.04B1.99B2.08B2.59B
Shares outstanding67.9M67.0M67.3M67.5M66.8M66.4M64.6M63.9M66.0M70.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations494.8M19.5M203.4M142.3M269.7M217.6M405.6M121.9M29.6M457.8M
Capital spending-288.4M-332.8M-441.4M-312.9M-284.6M-296.4M-138.1M-168.8M-123.1M-36.8M
Free cash flow206.4M-313.3M-238.0M-170.6M-14.8M-78.8M267.5M-46.9M-93.5M421.0M
Cash from investing-286.1M-336.9M-435.3M-312.3M-288.1M-330.8M-129.1M110.4M-65.7M-414.9M
Cash from financing-108.5M217.3M420.4M113.6M-69.3M96.3M-338.0M20.5M-361.8M-261.4M
Dividends paid-122.0M-127.7M-121.2M-124.3M-118.7M-114.9M-237.8M-241.1M-126.9M
Share buybacks2.65B1.85B0-423.7M
Change in cash101.9M-70.6M177.3M-38.6M-90.2M-16.3M-74.1M259.3M-414.5M-227.4M

Open Financials

Cap table

Built by 6ix from Bionime Corporation’s releases

Common shares
77,285,253
Fully diluted
77,285,253

Fully diluted

LineShares
Common shares77,285,253

Share count over time

CountShares
Nov 22, 202677,285,253

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
通化東寶藥業股份有限公司13.2M17.1%Oct 31, 2026
黃椿木3.09M4.0%Oct 31, 2026
研本投資股份有限公司1.85M2.4%Oct 31, 2026
賴春霖299K0.39%Oct 31, 2026
黃大祐241K0.31%Oct 31, 2026
劉美安118K0.15%Oct 31, 2026
陳碧萱116K0.15%Oct 31, 2026
葉智隆45,0000.06%Oct 31, 2026
黃千毓32,8420.04%Oct 31, 2026
陳界行31,6040.04%Oct 31, 2026
All 20 holders
HolderSharesOf the companyAs of
陳瑞鑫29,5340.04%Oct 31, 2026
陳雅雯22,0000.03%Oct 31, 2026
楊才毅9,0000.01%Oct 31, 2026
范朴00.00%Oct 31, 2026
陳世晃00.00%Oct 31, 2026
曾惠瑾00.00%Oct 31, 2026
劉克振00.00%Oct 31, 2026
張文海00.00%Oct 31, 2026
黃山溥00.00%Oct 31, 2026
通化東寶藥業股份有限公司Nov 21, 2026

Funds

HolderSharesValueAs of
Emerging Markets Core Equity 2 Portfolio244KUS$417KJul 31, 2026
The Emerging Markets Small Cap Series102KUS$175KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF44,191US$76,571Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF30,123US$52,195Jul 31, 2026
Emerging Markets Social Core Equity Portfolio13,536US$23,208Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio13,536US$23,208Jul 31, 2026
World ex U.S. Core Equity Portfolio13,536US$23,208Jul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio6,152US$10,548Jul 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Bionime Corporation.